235 results on '"Sathekge, Mike M."'
Search Results
2. Visualisation of in vivo protein synthesis during mycobacterial infection through [68Ga]Ga-DOTA-puromycin µPET/MRI
3. Prostate-specific Membrane Antigen: Alpha-labeled Radiopharmaceuticals
4. Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study
5. Prognostic Value of PSMA PET/CT in Prostate Cancer
6. ImmunoPET for prostate cancer in the PSMA era: do we need other targets?
7. Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer
8. Molecular Imaging of Tuberculosis
9. Imaging of Invasive Fungal Infections- The Role of PET/CT
10. [68Ga]Ga-NODAGAZOL uptake in atherosclerotic plaques correlates with the cardiovascular risk profile of patients
11. Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2
12. Evaluation of [ 68 Ga]Ga-DOTA-AeK as a Potential Imaging Tool for PET Imaging of Cell Wall Synthesis in Bacterial Infections.
13. Global experience with PSMA-based alpha therapy in prostate cancer
14. Impact of optimized PET imaging conditions on 18F-FDG uptake quantification in patients with apparently normal aortas
15. Comparison of MRI, [18F]FDG PET/CT, and 99mTc-UBI 29-41 scintigraphy for postoperative spondylodiscitis—a prospective multicenter study
16. An overview of the developments and potential applications of 68Ga-labelled PET/CT hypoxia imaging
17. [ 18 F]F-Poly(ADP-Ribose) Polymerase Inhibitor Radiotracers for Imaging PARP Expression and Their Potential Clinical Applications in Oncology.
18. A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases
19. Molecular imaging of cardiovascular inflammation and infection in people living with HIV infection
20. Arterial inflammation in young patients with human immunodeficiency virus infection: A cross-sectional study using F-18 FDG PET/CT
21. Imaging Molecular Targets and Metabolic Pathways in Breast Cancer for Improved Clinical Management: Current Practice and Future Perspectives.
22. 68Ga-PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?
23. Tuberculosis
24. Monitoring Response to Therapy
25. Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infections
26. Correction to: Global experience with PSMA‑based alpha therapy in prostate cancer
27. Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer
28. The role of F-18 FDG PET/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma
29. Radionuclide imaging of inflammation in atherosclerotic vascular disease among people living with HIV infection: current practice and future perspective
30. Correlation between [ 68 Ga]Ga-FAPI-46 PET Imaging and HIF-1α Immunohistochemical Analysis in Cervical Cancer: Proof-of-Concept.
31. 18F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma
32. Evaluation of a Flexible NOTA-RGD Kit Solution Using Gallium-68 from Different 68Ge/68Ga-Generators: Pharmacokinetics and Biodistribution in Nonhuman Primates and Demonstration of Solitary Pulmonary Nodule Imaging in Humans
33. Use of a Sentinel Lymph Node Biopsy Algorithm in a South African Population of Patients With Cervical Cancer and High Prevalence of Human Immunodeficiency Virus Infection
34. Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617
35. Recent Innovations and Nano-Delivery of Actinium-225: A Narrative Review.
36. Cryptococcoma of a transplanted kidney in a patient presenting with recurrent urinary tract infection: a case report
37. PET/CT imaging of Mycobacterium tuberculosis infection
38. Imaging fungal infections in children
39. Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma
40. A randomized-controlled study of a modified technique to reduce extracardiac activity in myocardial perfusion imaging
41. Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi 8 ,Met(O 2) 11 ]-Substance P.
42. The optimal TSH level necessary for successful radioiodine ablation of differentiated thyroid carcinoma, as well as the time to reach this level, is a work in progress
43. Imaging latent tuberculosis infection with radiolabeled nitroimidazoles
44. 68Ga‐nitroimidazole PET/CT imaging of hypoxia in tuberculosis: A case series.
45. Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer.
46. PET/CT features of a novel gallium-68 labelled hypoxia seeking agent in patients diagnosed with tuberculosis: a proof-of-concept study.
47. [68Ga]Ga-NODAGAZOL uptake in atherosclerotic plaques correlates with the cardiovascular risk profile of patients.
48. Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma.
49. 68 Ga-PSMA-11 PET/CT Initial Staging in Black and White South African Males with ISUP Grade Group 1 and 2 Prostate Adenocarcinoma.
50. The Use of 18 F-FDG PET/CT Metabolic Parameters in Predicting Overall Survival in Patients Undergoing Restaging for Malignant Melanoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.